Home / Import refusals / SCS-7401119-9/11/1

FDA Import Refusal SCS-7401119-9/11/1 — Santen Pharmaceutical Co Ltd

Santen Pharmaceutical Co Ltd — FEI 3010271740

The FDA refused shipment SCS-7401119-9/11/1 from Santen Pharmaceutical Co Ltd (Japan) on Dec 2, 2019. The refused product falls under Drugs and Biologics — DORZOLAMIDE HYDROCHLORIDE (ANTI-HYPERTENSIVE - PART II). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal details

Date
Dec 2, 2019
Country
Japan
Product Category
Drugs and Biologics
Product Code
62OAY26 DORZOLAMIDE HYDROCHLORIDE (ANTI-HYPERTENSIVE - PART II)
Charges
75

Other import refusals

FDA data resources

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.